TOKYO -- Japan's health ministry on Thursday approved Pfizer's COVID-19 pill Paxlovid for patients with mild to moderate symptoms, making it the second such oral medication to receive the fast-track treatment.
Coronavirus
Pfizer COVID pill approved in Japan, following Merck treatment
Concerns over supply emerge as nations race to secure drugs for their people
Pfizer's Paxlovid is a pill to treat COVID-19. © Reuters
Read Next
re.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Coronavirus
